Search
Patexia Research
Case number 2022-1060

NOF Corporation v. Nektar Therapeutics > Documents

Date Field Doc. No.Description (Pages)
Mar 2, 2022 5 ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [834201-2] filed by Cross-Appellant NOF Corporation. in 22-1003; issuing mandate. Service as of this date by the Clerk of Court. [834223] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 03/02/2022 08:45 AM] (2)
Nov 29, 2021 4 Certified list received. Service: 11/24/2021 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [814919] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 11/29/2021 09:06 AM] (190)
Oct 20, 2021 2 ORDER consolidating appeals (22-1003, 22-1004, 22-1008, 22-1060). The Certified Lists are due no later than November 24, 2021. Service as of this date by the Clerk of Court. [807070] [22-1003, 22-1060, 22-1004, 22-1008] [JCW] [Entered: 10/20/2021 03:14 PM] (0)
Oct 20, 2021 3 Note to File: The following cases are consolidated: 22-1003 Lead with 22-1004, 22-1008 Member Cases, 22-1060 Cross-Appeal. The parties must file all documents in the lead appeal only. [807071] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 10/20/2021 03:17 PM] (0)
Oct 15, 2021 1 Appeal docketed. Received: 10/14/2021. [805901] Entry of Appearance is due on 10/29/2021. Certificate of Interest is due on 10/29/2021. Docketing Statement is due on 10/29/2021. Certified List is due on 11/24/2021. [JCW] [Entered: 10/15/2021 10:24 AM] (0)
Menu